KRT14 and epidermolysis bullosa simplex: Currently, the identification of pathogenic variants in KRT5 or KRT14 by molecular genetic testing and confirmation by histological examination and immunofluorescence antigen mapping (IFM) are used for the diagnosis of EBS [19].